🔗 Share this article Social Media Influencers Fueling Unofficial Trade for Unapproved Slimming Medication A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings. Investigational Drug Acquiring Traction Via Social Media The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles privately for source information, while also obtaining discount codes. Active Trade on Social Networks Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions. Understanding The Experimental Drug This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic. Medical Experts Voice Worries However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin. Some professionals said the popularity for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro. Legal Status and Implementation Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012. Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking penalties, legal action or prison. Platform Response and Material Removal Based on TikTok, the platform has removed violative material and banned related keywords and query recommendations. The company said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies. Online Trading Activities Research also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at residence. Within minutes of joining one community, a vendor posted contact information, where most transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, medical conditions or past usage. Item Information and Costs Inside these communities, messages display dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.” Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”. Service Oversight and Safety Actions A representative for the messaging service stated it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”. Healthcare Expert Cautions “Individuals are injecting materials they can’t verify. Although the science behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said. Her staff has previously seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.” Manufacturer Statement A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose users to potentially significant health risks”.